The Zika virus might be scaring most of us, but it's exciting drug companies.

The World Health Organization reports that 15 pharmaceutical firms are engaged in a race to develop a vaccine to treat the mysterious illness that has left babies in Brazil disfigured and has pregnant women in Latin America and the United States worried.

A WHO official told the Wall Street Journal that it will be at least a year and a half before large-scale clinical trials can be underway. She was referring only to the two drugs that are considered as being in more advanced stages of development.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.